EpiWatch, Inc.
- Raised $190,000 (2024)
- 1 clinical trial
- FDA-cleared or approved devices
- Research grants: $551,094
Life science companies
Explore 12,266 biotech, pharmaceutical, medical device, CRO and CDMO companies. Filter by type, location, clinical trials, funding, FDA registrations and research focus, then see the insights or the map. Free, and new companies are added every day.
Revolution Medicines, Inc.
Nasdaq: RVMD
- Raised $100 million (2019)
- 23 clinical trials, 17 active
- Founded 2014
Sensus Healthcare, Inc.
Nasdaq: SRTS
- Raised $1.4 million (2013)
- 3 clinical trials
- FDA-cleared or approved devices
- Founded 2010
Xtant Medical Holdings, Inc.
NYSE: XTNT
- Raised $5 million (2024)
- FDA-cleared or approved devices
- Founded 2006
Zetagen Therapeutics, Inc.
- Raised $13 million (2025)
- 2 clinical trials, 1 active
- Research grants: $5.6 million
- Founded 2015
Exozymes Inc.
Nasdaq: EXOZ
- Raised $11,718 (2024)
- Research grants: $6.5 million
Nektar Therapeutics
Nasdaq: NKTR
- Raised $30 million (2024)
- 54 clinical trials, 3 active
RedHill Biopharma Ltd.
Nasdaq: RDHL
- Raised $10 million (2024)
- 19 clinical trials
- Founded 2009
ClearPoint Neuro, Inc.
Nasdaq: CLPT
- Raised $18 million (2026)
- FDA-cleared or approved devices
Arena Pharmaceuticals Inc
- Raised $36 million (2010)
- 17 clinical trials
- Research grants: $106,000
Edgewise Therapeutics, Inc.
Nasdaq: EWTX
- Raised $95 million (2020)
- 17 clinical trials, 5 active
- Founded 2017
Guided Therapeutics Inc
OTC: GTHP
- Raised $2.5 million (2015)
- 3 clinical trials, 1 active
- Research grants: $5.7 million
OrsoBio, Inc.
- Raised $40 million (2024)
- 5 clinical trials, 2 active
- Research grants: $4.6 million
- Founded 2020
Progenics Pharmaceuticals Inc
- Raised $13 million (2013)
- 17 clinical trials
- Research grants: $33 million
Thetis Pharmaceuticals LLC
- Raised $1.1 million (2022)
- 2 clinical trials, 1 active
- Research grants: $24 million
- Founded 2011
Traws Pharma, Inc.
Nasdaq: TRAW
- Raised $14 million (2024)
- 35 clinical trials, 4 active
VenoStent, Inc.
- Raised $10 million (2026)
- 2 clinical trials, 2 active
- Research grants: $8.3 million
- Founded 2017
Astex Pharmaceuticals, Inc
- Raised $3 million (2009)
- 47 clinical trials
- Research grants: $248,700
Trevi Therapeutics, Inc.
Nasdaq: TRVI
- Raised $55 million (2022)
- 16 clinical trials, 2 active
- Founded 2011
Teleflex Inc
NYSE: TFX
- 14 clinical trials, 4 active
- FDA-cleared or approved devices
Luminex Corp
- 7 clinical trials
- FDA-cleared or approved devices
- Research grants: $173,066
Aligos Therapeutics, Inc.
Nasdaq: ALGS
- Raised $105 million (2025)
- 15 clinical trials, 2 active
- Founded 2018
Moderna, Inc.
Nasdaq: MRNA
- Raised $451 million (2016)
- 125 clinical trials, 37 active
- Founded 2013
Lexeo Therapeutics, Inc.
Nasdaq: LXEO
- 8 clinical trials, 7 active
- Research grants: $5.9 million
PlenOptika, Inc.
- Raised $50,383 (2017)
- 1 clinical trial
- 1 FDA-registered device site
- Research grants: $4.7 million
Syncardia Systems Inc
- Raised $6.4 million (2014)
- 5 clinical trials
- FDA-cleared or approved devices
- Research grants: $606,498
Foundation Medicine, Inc.
- Raised $56 million (2013)
- 17 clinical trials, 2 active
- FDA-cleared or approved devices
- Founded 2009
Cogent Biosciences, Inc.
Nasdaq: COGT
- Raised $104 million (2020)
- 14 clinical trials, 6 active
- Founded 2014
Health Rhythms Inc.
- Raised $19 million (2023)
- 2 clinical trials
- Research grants: $14 million
Rational Vaccines, Inc.
- Raised $12 million (2022)
- 2 clinical trials
- Research grants: $4.7 million
- Founded 2015
vTv Therapeutics Inc.
Nasdaq: VTVT
- Raised $51 million (2024)
- 14 clinical trials, 2 active
- Founded 2015
Xilis, Inc.
- Raised $19 million (2025)
- 1 clinical trial
- Research grants: $7.6 million
- Founded 2019
Apnimed, Inc.
Nasdaq: APMD
- Raised $25 million (2026)
- 13 clinical trials, 1 active
- Founded 2017
Hillhurst Biopharmaceuticals, Inc.
- Raised $1.8 million (2023)
- 3 clinical trials, 1 active
- Research grants: $24 million
Pharmazz, Inc.
- Raised $10 million (2025)
- 13 clinical trials, 7 active
- Research grants: $554,118
- Founded 2017
Titan Pharmaceuticals Inc
- Raised $1.5 million (2022)
- 15 clinical trials
- Research grants: $495,000
Haemonetics Corp
NYSE: HAE
- 12 clinical trials, 1 active
- FDA-cleared or approved devices
Sequenom Inc
- Raised $85 million (2015)
- 26 clinical trials, 5 active
- Research grants: $373,984
BioCircuit Technologies, Inc.
- Raised $9 million (2022)
- FDA-cleared or approved devices
- Research grants: $19 million
- Founded 2016
Inbios International Inc
- 7 clinical trials
- FDA-cleared or approved devices
- Research grants: $16 million
Agios Pharmaceuticals, Inc.
Nasdaq: AGIO
- Raised $78 million (2011)
- 52 clinical trials, 15 active
- Founded 2007
Alume Biosciences Inc
- Raised $2.2 million (2026)
- 4 clinical trials, 1 active
- Research grants: $16 million
- Founded 2017
CytoDyn Inc.
OTC: CYDY
- Raised $19 million (2026)
- 24 clinical trials, 1 active
Beckman Coulter Inc
- 33 clinical trials, 2 active
- FDA-cleared or approved devices
Cypherpunk Technologies Inc.
Nasdaq: CYPH
- Raised $77 million (2023)
- 11 clinical trials
- Founded 2011
IDEAYA Biosciences, Inc.
Nasdaq: IDYA
- Raised $94 million (2018)
- 12 clinical trials, 12 active
- Founded 2015
Myosin Therapeutics Inc.
- Raised $3 million (2023)
- 2 clinical trials, 2 active
- Research grants: $23 million
- Founded 2020
Portola Pharmaceuticals Inc
- Raised $9 million (2011)
- 24 clinical trials
- Research grants: $720,330
PROFUSA, Inc.
- Raised $45 million (2018)
- 1 clinical trial, 1 active
- Research grants: $17 million
- Founded 2009
Relay Therapeutics, Inc.
Nasdaq: RLAY
- Raised $30 million (2024)
- 5 clinical trials, 4 active
Published company profiles only; counts update daily. Data licences